130 related articles for article (PubMed ID: 9920840)
1. Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner.
Lorand L; Velasco PT; Murthy SN; Lefebvre P; Green D
Blood; 1999 Feb; 93(3):909-17. PubMed ID: 9920840
[TBL] [Abstract][Full Text] [Related]
2. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
[TBL] [Abstract][Full Text] [Related]
3. Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.
Lopaciuk S; Bykowska K; McDonagh JM; McDonagh RP; Yount WJ; Fuller CR; Cooperstein L; Gray A; Lorand L
J Clin Invest; 1978 May; 61(5):1196-203. PubMed ID: 96136
[TBL] [Abstract][Full Text] [Related]
4. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
[TBL] [Abstract][Full Text] [Related]
5. Fibrin cross-linking in congenital factor XIII deficiency.
Rodeghiero F; Barbui T
J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
[TBL] [Abstract][Full Text] [Related]
7. Acquired plasma factor XIII deficiencies.
Tosetto A; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
[TBL] [Abstract][Full Text] [Related]
8. [Physiological significance of the fibrin stabilizing factor (factor XIII)].
Duckert F
Schweiz Med Wochenschr; 1974 Sep; 104(39):1342-7. PubMed ID: 4424195
[No Abstract] [Full Text] [Related]
9. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
[TBL] [Abstract][Full Text] [Related]
10. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII.
Greenberg CS; Achyuthan KE; Fenton JW
Blood; 1987 Mar; 69(3):867-71. PubMed ID: 2880615
[TBL] [Abstract][Full Text] [Related]
11. The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.
Souri M; Osaki T; Ichinose A
J Biol Chem; 2015 May; 290(19):12027-39. PubMed ID: 25809477
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets.
Greenberg CS; Shuman MA
J Biol Chem; 1984 Dec; 259(23):14721-7. PubMed ID: 6150044
[TBL] [Abstract][Full Text] [Related]
13. Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against actor XIII.
Lorand L; Velasco PT; Hill JM; Hoffmeister KJ; Kaye FJ
Thromb Haemost; 2002 Dec; 88(6):919-23. PubMed ID: 12529739
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.
Lorand L; Velasco PT; Rinne JR; Amare M; Miller LK; Zucker ML
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):232-6. PubMed ID: 3422419
[TBL] [Abstract][Full Text] [Related]
15. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
Lukacova D; Matsueda GR; Haber E; Reed GL
Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
[TBL] [Abstract][Full Text] [Related]
17. Measurement of factor XIII activity in plasma.
Katona É; Pénzes K; Molnár É; Muszbek L
Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
[TBL] [Abstract][Full Text] [Related]
18. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
Krumdieck R; Shaw DR; Huang ST; Poon MC; Rustagi PK
Am J Med; 1991 May; 90(5):639-45. PubMed ID: 1903026
[TBL] [Abstract][Full Text] [Related]
20. Association of the A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma.
Radek JT; Jeong JM; Wilson J; Lorand L
Biochemistry; 1993 Apr; 32(14):3527-34. PubMed ID: 8466897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
